Psychedelic Medicine

Association

The Psychedelic Medicine Association Journal Club June 2024

* Use this button to RSVP to the event on our PMA Community Platform!

Haven't joined the new community yet? Use this button to complete your profile and enjoy our new streamlined webinar registration process!

Log in To Watch the Recording

*Exclusive for members.

Thursday, June 27th at 5 pm Pacific, 8 pm Eastern >> Log in to Watch the Recording >>

Join Us For The Summer 2024 Edition Of:

The Psychedelic Medicine Association Journal Club

Host:

Lynn Marie Morski, MD, JD

Lynn Marie Morski, MD, JD

President, Psychedelic Medicine Association

Panelists:

Jared Morningstar

Jared Morningstar

Content Manager, Psychedelic Medicine Association

Jared is a writer and educator with a BA in religion for which he completed a thesis project comparing DMT-induced mystical experiences and traditional religious mystical experiences. At the Psychedelic Medicine Association he helps organize monthly webinars, compiles recent psychedelic research for the newsletters, writes accessible overview articles on various psychedelic medicines, and manages social media profiles.

Victoria Wueschner

Victoria Wueschner

President & Co-Founder, F.I.V.E.

Specializing in 5-MeO-DMT, Victoria has dedicated her path to cultivating safe and effective approaches to working with the molecule. After being immersed in the psychedelic space for well over a decade honoring her own path, Victoria stepped into the role of medicine facilitator where she chose to work primarily with 5-MeO-DMT. After immersing herself in the 5-MeO community and multiple trainings, she began her work as a retreat leader at Tandava Retreats in Mexico.

In addition to leading retreats, Victoria is also the co-founder and president of F.I.V.E (5-MeO-DMT Information and Vital Education), a harm reduction platform focused on education, training, research and more. Her aim is to bring awareness to the ethics, integrity, and safety of 5-MeO-DMT. As a result, she collaborated with top experts in the field to develop the worlds most comprehensive 5-MeO-DMT training program, where she currently serves as an educator.

Rebecca Kronman, LCSW

Founder, Plant Parenthood

Rebecca Kronman, LCSW is a licensed therapist and founder of Plant Parenthood, a digital and in-person community of parents who use psychedelics. She is also an assisting trainer with Fluence, a company that trains healthcare practitioners in harm reduction informed psychedelic preparation and integration. At her private practice in Brooklyn, she works with creative professionals using mindfulness and experiential techniques to address depression, anxiety and life transitions. She also helps clients prepare for psychedelic experiences, incorporate insights or cope with challenges post-experience. Selected trainings include Mindfulness Based Stress Reduction, Mindfulness for Clinicians, Psychedelics 101 & 102 and Beyond Experience Psychedelic Integration Workshop.

Reid Robison, MD, MBA

Chief Medical Officer at Novamind/Co-founder at Cedar Psychiatry

Dr. Reid Robison is a board-certified psychiatrist and Chief Medical Officer at Novamind. Reid is co-founder at Cedar Psychiatry and serves as Medical Director of Center for Change, a top Eating Disorder program. He is currently the coordinating investigator for the MAPS MDMA-assisted Psychotherapy study of Eating Disorders. Reid is adjunct faculty at the University of Utah, founder of the Polizzi Free Clinic, and provides medical support and psychedelic therapy at plant medicine retreats abroad.

At the Psychedelic Medicine Association, we’re always looking for ways to provide you even more value—both in education on psychedelics and in networking with your fellow members. And we figured a great way to do both at the same time was to start the Psychedelic Medicine Journal Club! 

As many of you may have experienced during school or residency, a journal club is a gathering where all attendees read the same journal article and discuss it in-depth to provide an even greater understanding of the material—all while getting to know each other even better).

This month’s journal club will be led by Psychedelic Medicine Association team member Jared Morningstar, and the article we will be discussing is “Expectancy in placebo-controlled trials of psychedelics: if so, so what?” We’ll use this article as a jumping-off point for discussing the complexities of placebo-controlled studies in the context of psychedelic research more broadly. 

This will be an interactive format where everyone is encouraged to turn on their camera and share your thoughts on the article—as well as meet your fellow PMA members!

So please join us for this live journal club discussion on Thursday, June 27th at 5 pm Pacific, 8 pm Eastern. This is exclusively for members of the Psychedelic Medicine Association, so if you have not yet registered, please do so here. And for members, please register for the panel here. A link to the recording will be available afterward if you cannot make it to the live event.

Hope to see you all on the 27th!

You can find the Psychedelic Medicine Association on Twitter, LinkedIn, and on Facebook.